Social News
Written by: Lin Yingxian
2021-04-29 19:51
Last update date: 2021-04-29 19:51
The new crown vaccination plan has been launched for two months. The Vaccine Advisory Expert Committee met again today (29th) to assess the continued effectiveness and risk of approved vaccines. After reviewing the latest clinical and safety data of all Fubitai and Kexing vaccines, the committee still believes that The benefits of both vaccines outweigh the risks, and there is no need to suggest changes to the use of these two vaccines.
The Vaccine Advisory Expert Committee met again today to review the latest data on Fubitai and Kexing vaccines, and believe that the benefits of the two vaccines are greater than the wind (Photo by Li Zetong)
Chilean vaccine research: 14 days after vaccination with Kexing, the prevention rate is 66.96%
Liu Zexing, the convener of the Vaccine Advisory Expert Committee, chaired today’s meeting. With regard to Kexing Vaccine, preliminary data from a Chilean vaccine effectiveness study showed that the effectiveness of preventing symptomatic new coronary pneumonia 14 days after inoculation with Kexing vaccine was 66.96%. The committee considers the current Hong Kong After the overseas safety data, including the safety reports that have been submitted, it is believed that no new important safety signals have been discovered, but continuous monitoring is required. The quality of the imported Coxing vaccines has also passed certification and appropriate quality control tests.
▼On April 24, the vaccination program will be extended to people 16 years of age or older▼
Fubitel's latest clinical data: 7 days after the second injection, the effective rate is about 90%
As for the Fubitai vaccine that had been banned due to leakage earlier, the committee believed that the pharmaceutical factory confirmed that the quality of the vaccine was not compromised. It believed that there was no evidence that the affected batch of vaccines had a safety risk. The Fubitai vaccine was subsequently imported for vaccination. The quality of the vaccine has passed certification and appropriate quality control tests.
The latest data from the continuous Phase 3 clinical test of Fubitel vaccine and the data obtained by those who have been vaccinated all show that 7 days after the second injection, the effective rate is maintained at about 90%. The committee also believes that Fubitel vaccine There is no new security alarm, but continuous monitoring is required.
The committee will submit relevant opinions to the Secretary for Food and Health, and will also upload them to the authority's website later.
Tseung Kwan O Hospital 76-year-old Weng died on Monday night and received the second dose of new crown vaccine three weeks ago
A total of 860,000 people have been vaccinated against the new crown 5 women were admitted to the hospital with a rash after getting Bita on Sunday
New crown vaccine│Zhang Jianzong hopes to restore business atmosphere within the year and calls on citizens to be vaccinated
New crown vaccine | 7 people were admitted to hospital after being vaccinated
New Crown Vaccine | Dr. Mary's Cerebral Hemorrhage After Recovering Bitte, Kong Fanyi: More Clinical Data Needed
01News
New crown pneumonia new crown vaccine vaccine vaccination China Kexing BioNTech/Fosun vaccine Fubitai vaccine new crown vaccine side effects Food and Health Bureau
